Trump orders revamping of care for kidney disease

DaVita Fresenius Medical Fall on Trump Overhaul Report

Trump orders revamping of care for kidney disease

Ensuring 80% of new kidney failure patients in 2025 either are receiving dialysis at home or are receiving a transplant. Azar has also previously said the department was looking at ways to modernize payments for patients in the earlier stages of kidney disease. Shares of both companies have fallen this week as news of the plan leaked out, with DaVita down 7.6% despite a gain on Wednesday morning, and Fresenius down 3.8%.

The president's address on kidney health comes as his administration faces intense scrutiny over the president's past friendship with indicted billionaire Jeffrey Epstein, and Labor Secretary Alex Acosta's handling of a past case involving Epstein.

The announcements today serve also as a strong platform for building momentum for the community's Kidney Care FIRST framework for the future of kidney care.

President Trump's executive order lays out new payment models in Medicare and Medicaid for renal disease treatments that are meant to allow flexibility in how care is delivered based on patient's individual needs.

Today's system favors expensive, time-consuming dialysis in large centers-what Trump called so onerous "it's like a full-time job"-over easier-to-tolerate at-home care or transplants that help patients live longer". On Tuesday, the Trump administration was in a federal appeals court in New Orleans arguing the entire health law should be declared unconstitutional.

KCP looks forward to continuing working with the Administration and Congress to put patients first and thanks them for their leadership in advancing kidney care. Of that, $35 billion went to patients in the late stages of kidney failure, who need dialysis, according to a government-funded data registry. Kidney disease accounts for roughly one in five dollars spent in Medicare, totaling $113 billion in 2016.

"With today's action, we're making crucial progress on another core national priority: the fight against kidney disease", Trump said at a speech prior to signing the order.

DaVita operates more than 2,500 dialysis centers in the USA and generated $10.3 billion in sales from dialysis in 2018. Patients are shunted to dialysis centers as a default, and once on it, they "rarely switch", he said.

"There is general sense there is under-utilization of home dialysis and under-exposure to to it", said Jeffrey Berns, a nephrologist at the University of Pennsylvania. Nichole Jefferson, 47, of Dallas, who is awaiting a second transplant to replace a transplanted kidney that is failing, said getting the treatment at home is much less taxing. A shortage of kidneys for transplant kills about 43,000 people every year.

HHS will also encourage the development of wearable or implantable artificial kidneys, through cooperation between developers and the Food and Drug Administration, and provide support for KidneyX, the public-private partnership between HHS and the American Society of Nephrology. The mortality rate for people with kidney disease makes it the ninth leading cause of death in the United States.

Azar said he believes it's possible to double the number of kidneys available for transplant by 2030. Azar's father suffered from end-stage kidney disease.

Beneficiaries themselves would not see a change in their Medicare cost-sharing and keep existing protections under the new value-based system.

"We have gone through changes in iPhones and computers and the way we do defibrillators", Parikh said. Kidney transplants cost less than having patients spend years on dialysis, according to government figures.

Comments are disabled on some stories about sensitive topics.

Latest News